2025-07-16 - Analysis Report
Okay, here's the analysis of Teladoc Health Inc (TDOC) based on the provided data, structured as requested.

## Teladoc Health Inc (TDOC) Analysis

**TDOC: Teladoc Health Inc is a virtual healthcare company providing telehealth services, including remote medical consultations.**

### 1. Performance vs. S&P 500 (VOO)

*   **TDOC Cumulative Return:** -64.91%
*   **VOO Cumulative Return:** 96.08%
*   **Absolute Divergence:** -159.5
*   **Relative Divergence:** 0.1

**Analysis:** TDOC has significantly underperformed the S&P 500 (VOO) over the period considered. The substantial negative divergence indicates considerable underperformance compared to the broader market. The relative divergence value of 0.1 suggests the current divergence is near the lower end of its historical range.

**Alpha, Beta Analysis**

| Year       | CAGR     | MDD     | Alpha    | Beta   | Cap(B) |
|------------|----------|---------|----------|--------|--------|
| 2015-2017  | 76.0%   | 60.6%   | 50.0%   | -0.0   | 6.1     |
| 2016-2018  | 128.0%  | 59.3%   | 110.0%  | -0.0   | 8.7     |
| 2017-2019  | 176.0%  | 59.3%   | 147.0%  | 0.4    | 14.7    |
| 2018-2020  | 237.0%  | 64.0%   | 217.0%  | 0.1    | 35.1    |
| 2019-2021  | -83.0%  | 64.0%   | -132.0% | 0.1    | 16.1    |
| 2020-2022  | -295.0% | 81.3%   | -297.0% | 0.0    | 4.2     |
| 2021-2023  | -488.0% | 81.3%   | -506.0% | -0.6   | 3.8     |
| 2022-2024  | -111.0% | 81.3%   | -137.0% | -0.8   | 1.6     |
| 2023-2025  | -36.0%  | 72.9%   | -83.0%  | -0.8   | 1.4     |

**Analysis:**

*   **Early Growth (2015-2020):** Significant CAGR and high Alpha indicate strong outperformance, though with considerable MDD (Maximum Drawdown).  The low Beta suggests the stock was relatively independent of market movements during this period.
*   **Recent Struggles (2019-2025):**  Substantial negative CAGR and Alpha values reveal considerable underperformance and value destruction.  Increasingly negative Beta values suggest a negative correlation with the market recently (i.e., it tends to move in the opposite direction of the market).
*   **Capitalization Decline:** The market capitalization (Cap) has drastically decreased, reflecting the declining investor confidence and stock price.

### 2. Recent Stock Price Movement

*   **Current Price:** 7.91
*   **Previous Close:** 8.27
*   **Price Change:** -4.35%
*   **5-Day Moving Average:** 8.432
*   **20-Day Moving Average:** 8.0285
*   **60-Day Moving Average:** 7.4152

**Analysis:** The stock price has recently decreased, falling below both the 5-day and 20-day moving averages, although it is still above the 60-day moving average.  The negative change from the previous close suggests continued downward pressure.

### 3. Market Risk Indicator (MRI) and Other Technical Indicators

*   **MRI:** 0.341 (Low Risk)
*   **RSI:** 48.85
*   **PPO:** -0.4678
*   **Hybrid Signal:** cash_70%_Sell 70.0% of holdings
*   **Recent (20-day) Relative Divergence Change:** 0.1 (+)
*   **Expected Return (%):** -9588.8%

**Analysis:**

*   **MRI:** The MRI indicates "Low Risk" which, in this context, is a caution signal given the company's poor performance. This suggests that while the market might not perceive high risk, the underlying fundamentals warrant caution.
*   **RSI:** The RSI is near the neutral level, indicating neither overbought nor oversold conditions.
*   **PPO:** The negative PPO suggests a downtrend.
*   **Hybrid Signal:** The hybrid signal recommends selling 70% of holdings and increasing cash position to 70%, reinforcing the cautious outlook.
*   **Relative Divergence Change:**  The slight increase in relative divergence over the last 20 days indicates a minor improvement in TDOC's performance relative to the S&P 500, but this is marginal given the overall divergence.
*   **Expected Return:** The extremely negative expected return suggests a highly pessimistic outlook for future performance relative to the S&P 500, if investing at this time and with long term investment horizon (2 years+).
*   **Price Change Impact:** The `{'price': 7.91, 'previousClose': 8.27, 'change': -4.35}` data confirms a significant price drop, indicating potential short-term volatility and negative investor sentiment.

### 4. Recent News & Significant Events

*   **2025-07-13:**  Major business developments, regulatory changes, or market events.
*   **2025-07-14:**  Analyst discussions on recent performance and outlook.
*   **2025-07-15:**  Notable stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-07-12:**  Market experts highlight risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The news headlines suggest recent volatility and scrutiny surrounding TDOC, indicating potential uncertainty and market reactions to company-specific events.

### 5. Recent Earnings Analysis

| Date       | EPS   | Revenue    |
|------------|-------|------------|
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2024-04-26 | -0.49 | 0.65 B$   |
| 2025-05-01 | -0.49 | 0.65 B$   |

**Analysis:**

*   **Negative EPS:** Teladoc Health consistently reports negative Earnings Per Share (EPS), indicating a lack of profitability.
*   **Stable Revenue:** Revenue remains relatively stable, around $0.63-0.65 billion per quarter.  However, this stable revenue is not translating into profitability.
*  **Inconsistency:** The re-occurrence of the 2025-05-01 data point (both EPS and revenue) raises a question about data accuracy.

### 6. Financial Information

**Revenue and Profitability**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.63B  | 68.73%        |
| 2024-12-31 | $0.64B  | 70.50%        |
| 2024-09-30 | $0.64B  | 71.94%        |
| 2024-06-30 | $0.64B  | 70.73%        |
| 2024-03-31 | $0.65B  | 69.89%        |

**Capital and Profitability**

| Quarter    | Equity  | ROE      |
|------------|---------|----------|
| 2025-03-31 | $1.43B  | -6.52%   |
| 2024-12-31 | $1.49B  | -3.25%   |
| 2024-09-30 | $1.51B  | -2.21%   |
| 2024-06-30 | $1.50B  | -55.77%  |
| 2024-03-31 | $2.29B  | -3.58%   |

**Analysis:**

*   **Consistent Revenue:** Revenue remains stable, similar to the earnings data.
*   **High Profit Margins:** The company reports high-profit margins, suggesting effective cost control *at the operational level*. This highlights that the losses are likely due to other factors (e.g., high interest expense, large one-time write-offs).
*   **Declining Equity:** Equity is decreasing, indicating the company is losing value.
*   **Negative ROE:**  Return on Equity (ROE) is consistently negative, confirming the company is not generating profits from its equity base. The dramatic drop in ROE in Q2 2024 warrants further investigation.

### 7. Overall Summary

Teladoc Health Inc (TDOC) is facing significant challenges. The company has significantly underperformed the market, with negative cumulative returns and a large divergence from the S&P 500. Recent stock price movements indicate continued downward pressure. Although the company reports stable revenue and high-profit margins, it struggles with profitability, as evidenced by negative EPS and ROE. The Market Risk Indicator (MRI) signals "Low Risk," but this should be interpreted with caution given the company's poor performance. The Hybrid Signal suggests selling holdings, reinforcing the cautious outlook. Recent news headlines indicate volatility and scrutiny. The expected return is extremely negative. Overall, the data suggests a bearish outlook for TDOC.
